Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
Alzheimer’s Disease
ALPHA-1062
Traumatic Brain Injury
Amyotrophic Lateral Sclerosis
ALPHA-0602
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Contact
Menu
Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
Alzheimer’s Disease
ALPHA-1062
Traumatic Brain Injury
Amyotrophic Lateral Sclerosis
ALPHA-0602
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Contact
Bringing hope
to people living with Alzheimer’s disease and ALS
Investor Presentation
Latest News Release
09.23.2021
Alpha Cognition Announces Pricing of Public Offering
Read More
Treatments
Alzheimers: ALPHA-1062
A New Approach
Read More
Quick Links
About ACI
ALPHA-0602
Team
Contact
Latest News
View All
09.23.2021
Alpha Cognition Announces Pricing of Public Offering
Read More
09.22.2021
Alpha Cognition Announces Overnight Marketed Offering
Read More
View All
TSX-V: ACOG
15 min delay
Last
$1.32
Change
$-0.03
Open
1.34
Vol
47,400
High
1.34
Low
1.25
Stock Information
